Bacordo, Helenda T.

HRN: 10-84-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2026
CEFTRIAXONE 1G (VIAL)
01/25/2026
02/01/2026
IV
2g
OD
UTI
Remove - Pending Acceptance
01/29/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/29/2026
02/05/2026
IV
3.375g
Q6Hrs
Sepsis, Complicated UTI
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: